Jane E. Caskey

Global Chief Client Officer and Head of Risk Advisory
Norton Rose Fulbright LLP

London
United Kingdom
T:+44 20 7444 3811
London
United Kingdom
T:+44 20 7444 3811
Jane E. Caskey

Jane E. Caskey

vCard

Related services and key industries

Related services



Key industry sectors



Biography

Jane Caskey is global chief client officer and global head of our risk advisory practice. She currently sits as a member of our global management team.

As chief client officer, Jane is responsible for formulating and driving an aligned and integrated client-facing strategy to generate global and cross-border connectivity for clients, focusing on the firm's industry sectors, practice groups, client program and panel clients, as well as its risk advisory and client intelligence offering.

Jane's risk advisory practice involves working with global clients to identify, mitigate, and manage key risks across their businesses in a holistic and strategic manner, across business units and geographies, which includes analyzing the current and emerging risks within the context of the commercial goals of our clients and their risk culture and appetite. Jane's background is intellectual property law, including all aspects of trademarks and patent litigation. She has specialized knowledge of remedies, including complex transfer pricing and damages issues and recovery. She is also involved in advising clients on strategy for protecting IP rights, including, trade secrets and data in relation to digital and cyber risks.

Ms. Caskey has extensive experience in resolving client issues through negotiation/alternative dispute resolution and has broad experience as an advocate on arbitrations and mediations.

Professional experience

Expand all Collapse all
LL.B., McGill University, 1994
B.A. (Hons.), Western University, 1991
  • Ontario 1996
  • Canada (trademarks) 2007

Ms. Caskey has acted for the following clients:

  • On S+P 400 consumer products company on risk-based due diligence and subsequent transaction in an acquisition across more than 45 countries
  • A US bank in respect to a sensitive AML audit
  • An international consumer health company on a global risk and conduct controls GAP analysis and audit
  • A global pharmaceutical company on crisis management preparation
  • Pfizer Inc. in relation to damages in section 8 and infringement disputes for Lipitor
  • GlaxoSmithKline in relation to multiple patent infringement actions and damages references, section 6 and section 8 PM(NOC) proceedings for numerous drugs, including RETROVIR, COREG, AVODART, and VALTREX
  • Merck in relation to a damages reference following a judgment of infringement and validity of Merck's patent for lisinopril
  • Eli Lilly in multiple patent infringement and section 6 PM(NOC) proceedings
  • Boehringer Ingelheim providing patent strategic advice
  • Warner Chilcott plc in its acquisition and financing of Procter & Gamble's worldwide pharmaceuticals business for US$3.1 billion and its regulatory, market access and branding strategy
  • Best Lawyers in Canada: Intellectual Property Law, 2013-2021
  • BTI Client Service All-Star, The BTI Consulting Group, Inc., 2020
  • Chambers Canada, Nationwide: Intellectual Property - Litigation, Chambers and Partners, 2018
  • Managing IP Stars (2018): IP Star – Patent Star Canada
  • Chambers Global: Canada, 2012-2018: Intellectual Property: Litigation, 2018
  • Canadian Legal Lexpert Directory (2018): recommended in Intellectual Property Law
  • World Trademark Review (2013-2018) – expert in enforcement and litigation
  • The Legal 500 Canada (2016): Intellectual Property: Litigation
  • Ranked under "Trade Mark" in Legal Media Group's Guide to Leading Women in Business Law, 2014
  • 2012 Canada's Most Powerful Women: Top 100™ Award Winner
  • Ranked "Excellent" under Patent Litigation and Trademarks by Leaders League: Innovation – Technology & Intellectual Property (2011)
  • Lexpert's Leading Litigators to Watch (2008)
  • Lexpert's Top 40 Under 40 (2007)
  • "Crisis Management," Northwind, September 26, 2017.
  • "Disconnect in the Canadian Courts' Approach to Drug Patents - Favouring Economic Rights over Exclusivity yet Falling Short on Compensation," Insight, January 2006.
  • "Intellectual Property License Agreements (Patents and Trade-marks): Obligations of the Licensee," The Canadian Institute, December 8, 2004.
  • International Trademark Association
  • Canadian Bar Association
  • Intellectual Property Owners Association
  • Intellectual Property Institute of Canada
  • The Advocates' Society
  • IP Osgoode Law School
  • Huron University College Corporation
  • Women's Law Association (former director)
  • Society of Obstetricians and Gynaecologists of Canada (former director)

News

All related news

Insights

Financial Services Regulatory Developments in ESG

Publication | May 16, 2023

Managing geopolitical risk

Publication | December 01, 2022

Beyond COVID-19: Crisis response or road to recovery?

Update | November 18, 2022

All related insights